Vogo-M 0.3 Tablet

By Vogo-M

Rx

10 Tablet in a Strip

Composition icon

Composition

Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Alembic Pharmaceuticals Ltd icon

Manufacturer - Alembic Pharmaceuticals Ltd

Alembic Road, Vadodara - 390 003, Gujarat,INDIA

Expires on or after icon

Expires on or after

March, 2026

About Vogo-M 0.3 Tablet

Vogo-M 0.3 Tablet falls under the category of anti-diabetic medications. Primarily designed to address type 2 diabetes mellitus in adult patients, it serves the critical function of regulating blood sugar levels in individuals with diabetes. For optimal results, this tablet is meant to be consumed with food consistently at the same time each day as directed by your healthcare provider. The dosage will be determined by your doctor and may be adjusted based on your blood sugar levels and response to the medication.

It is imperative to adhere to the prescribed regimen even if you feel well or your blood sugar appears to be under control. Abruptly discontinuing the medication without seeking medical advice can lead to a spike in blood sugar levels, potentially resulting in serious complications such as kidney issues, vision impairment, nerve damage, and even amputation in severe cases. Vogo-M 0.3 Tablet is an integral part of a comprehensive treatment plan that should encompass healthy dietary choices, regular physical activity, and weight management strategies recommended by your healthcare provider – collectively vital in managing diabetes effectively.

While Vogo-M 0.3 Tablet is generally well-tolerated, some individuals may experience transient side effects such as nausea, changes in taste perception, reduced appetite, bloating, abdominal discomfort, diarrhea, or skin irritation. These effects typically diminish on their own; however, if persistent or concerning, seeking medical guidance is advisable so that appropriate measures can be instituted to alleviate or manage these potential drawbacks effectively.

Certain individuals should avoid taking this medication, including those with type 1 diabetes mellitus, diabetic ketoacidosis (characterized by elevated blood acidity levels), or severe liver or kidney impairment. Prior to initiating treatment with Vogo-M 0.3 Tablet, individuals with a history of heart disease should inform their healthcare provider, as this medication may not be suitable for them. Pregnant or nursing women should also seek medical advice before incorporating this medication into their regimen. Regular monitoring of blood sugar levels, along with periodic blood tests to assess blood cell counts and liver function, are fundamental aspects of managing diabetes while on this medication regimen.


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

110

Inclusive of all taxes

Content verified by

chevron-right

Dr. Abdullah Khan

MBBS - General Medicine

Last update on 01-Oct-2024